Home > Financial Ratios > ANUH PHARMA

ANUH PHARMA
EV/Core EBITDA

    Back to All Ratios
ANUH PHARMA is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for ANUH PHARMA
Please provide your vote to see the results

ANUH PHARMA Last 5 Year EV/Core EBITDA History

[Standalone]

Mar2024Mar2023Mar2022Mar2021Mar2020
   EV/Core EBITDA(x) 13.926.777.948.0112.17

What is the latest EV/Core EBITDA ratio of ANUH PHARMA ?

The latest EV/Core EBITDA ratio of ANUH PHARMA is 13.92 based on Mar2024 Standalone results.
Year EV/Core EBITDA
Mar202413.92
Mar20236.77
Mar20227.94
Mar20218.01
Mar202012.17

How is EV/Core EBITDA of ANUH PHARMA Trending?

Years EV/Core EBITDA % Change
Mar2024 13.92
105.61
Mar2023 6.77
-14.74
Mar2022 7.94
-0.87
Mar2021 8.01
-34.18
Mar2020 12.17 -

Other Financial Ratios of ANUH PHARMA


Compare EV/Core EBITDA ratio of peers of ANUH PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
ANUH PHARMA ₹1,015.8 Cr -9.2% -8.2% 27.9% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹418,936.0 Cr -5.8% -3.2% 35.1% Stock Analytics
DIVIS LABORATORIES ₹152,157.0 Cr -2.8% -3.6% 44.7% Stock Analytics
CIPLA ₹116,200.0 Cr -3.9% -0.5% 13.9% Stock Analytics
DR REDDYS LABORATORIES ₹111,325.0 Cr -1.2% 7.1% 17.8% Stock Analytics
ZYDUS LIFESCIENCES ₹98,037.4 Cr -2.7% -0.1% 40.9% Stock Analytics


ANUH PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
ANUH PHARMA

-9.2%

-8.2%

27.9%

SENSEX

-2.1%

-6.4%

7%


You may also like the below Video Courses